Long-Term Assets: The sum of all assets classified as non-current.
Biostar Pharmaceuticals, Inc. (BSPM) had Long-Term Assets of $35.14M for the most recently reported fiscal year, ending 2016-12-31.
| Income Statement Financials | |
$2.38M |
|
$-5.70M |
|
$1.47M |
|
$0.92M |
|
$5.95M |
|
$-3.56M |
|
$0.52M |
|
$-3.05M |
|
$-3.05M |
|
$-5.70M |
|
$-5.70M |
|
$-5.70M |
|
$-5.70M |
|
$-3.56M |
|
$-2.42M |
|
2.30M |
|
2.30M |
|
$-2.50 |
|
$-2.50 |
|
| Balance Sheet Financials | |
$7.37M |
|
$5.87M |
|
|
Long-Term Assets |
$35.14M |
$42.50M |
|
$5.62M |
|
-- |
|
-- |
|
$5.62M |
|
$36.88M |
|
$31.27M |
|
$36.88M |
|
2.64M |
|
| Cash Flow Statement Financials | |
$4.91M |
|
$-6.38M |
|
$1.41M |
|
$0.04M |
|
$0.17M |
|
$0.13M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.31 |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
38.38% |
|
-149.48% |
|
-149.48% |
|
-101.56% |
|
-127.71% |
|
-238.98% |
|
$4.91M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
8.82 |
|
0.35 |
|
1049.19 |
|
-15.45% |
|
-18.22% |
|
-13.41% |
|
-15.45% |
|
$13.99 |
|
$2.14 |
|
$2.14 |
|